October 02, 2014 1:00 AM ET


Company Overview of Talima Therapeutics, Inc.

Company Overview

Talima Therapeutics, Inc., a specialty pharmaceutical company, engages in the development and commercialization of site-specific drug delivery systems. Its product under clinical testing is a micro implant that delivers a broad-acting small molecule to the site of infection for the treatment of onychomycosis, a fungal disease of the nails. The company was founded in 2004 and is based in Santa Clara, California.

2255 Martin Avenue

Suite F

Santa Clara, CA 95050

United States

Founded in 2004





Key Executives for Talima Therapeutics, Inc.

Chief Executive Officer
Age: 49
Chief Financial Officer
Vice President of Operations
Chief Medical Officer
Age: 65
Vice President of Research and Development
Age: 55
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Ophtalox, Inc. United States
StageMark, Inc. United States
Anpa Medical Inc. United States
Novan, Inc. United States
West Coast Fermentation Center, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Talima Therapeutics, Inc., please visit www.talima.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.